Skip to content

Novo Nordisk sues Eli Lilly over ads comparing GLP-1 medications

Stocks & Finance

The drugmaker says Lilly isn’t including the most up-to-date clinical information about its drugs


Source: MarketWatch Top Stories — This article was automatically imported from the source. Read full article at original source →

MA
Originally published by MarketWatch Top Stories marketwatch.com
Visit original article

admin

Leave a Comment